← All stocks

4D Molecular Therapeutics, Inc.

FDMT Scheduled selling only

CIK 0001650648 #2652 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$1.93M

$811.00K on a plan · $1.12M straight out of an exercise

Sold at will

$0.00

0 of 5 sales

Net

−$1.93M

$0.00 against sales at will

By person

6 insiders · 5 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Kirn David

See Remarks

—

$1.90M (3) scheduled

−$1.90M

767,486

1.39%

$10.67M

−27.5%

Bizily Scott

Chief Legal Officer

—

$28.12K (2) scheduled

−$28.12K

8,617

0.0156%

$119.80K

−42.7%

RA CAPITAL MANAGEMENT, L.P. entity

10% owner

—

4,563,211

8.26%

$63.44M

−10.5%

BVF PARTNERS L P/IL entity

See Explanation of Responses

—

87,911

0.1592%

$1.22M

−98.5%

Gupta Ashoo

VP, Finance and Controller

—

47,055

0.0852%

$654.21K

+3.1%

THEUER CHARLES

Director

—

41,684

0.0755%

$579.53K

+28.8%

Individual transactions

Insider

Date

Role

Action

Price

Amount

Kirn David

14 Sep 2026

See Remarks

Sold on a plan

58,333

$13.90

$811.00K

Show all 5 transactions →

What was left out

Form 4 filings counted 4

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 1

Sales straight out of an exercise 4

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 52,219

History held since 17 Dec 2020